These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8330346)

  • 1. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS; Haseman JK; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
    Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
    Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
    Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
    Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
    Hansen LA; Tennant R
    Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
    Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
    Thompson KL; Rosenzweig BA; Honchel R; Cannon RE; Blanchard KT; Stoll RE; Sistare FD
    Mol Carcinog; 2001 Dec; 32(4):176-86. PubMed ID: 11746829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.
    Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW
    Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis.
    Chan EL; Peace BE; Toney K; Kader SA; Pathrose P; Collins MH; Waltz SE
    Mol Carcinog; 2007 Jan; 46(1):49-59. PubMed ID: 17013830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
    Hansen LA; Trempus CS; Mahler JF; Tennant RW
    Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
    Smith MK; Trempus CS; Gilmour SK
    Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis of skin tumor data from Tg.AC mouse bioassays.
    Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW
    Toxicol Sci; 2000 Jun; 55(2):293-302. PubMed ID: 10828260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA; Spalding JW; French JE; Tennant RW
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase mRNA is upregulated in skin tumors of v-ha-ras transgenic TG-AC mice treated with 12-o-tetradecanoylphorbol-13-acetate.
    Lee BM; Kim HS; Jeohn GH
    Biol Pharm Bull; 2000 Jul; 23(7):826-9. PubMed ID: 10919360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.